Smith & Nephew plc (LON:SN.)

Market Cap	11.67B
Revenue (ttm)	4.33B
Net Income (ttm)	358.03M
Shares Out	847.68M
EPS (ttm)	0.41
PE Ratio	33.83
Forward PE	17.11
Dividend	0.29 (2.04%)
Ex-Dividend Date	Oct 2, 2025

Volume	1,883,253
Average Volume	3,682,571
Open	1,370.50
Previous Close	1,367.50
Day's Range	1,364.50 - 1,406.00
52-Week Range	911.00 - 1,441.50
Beta	0.67
RSI	58.21
Earnings Date	Oct 30, 2025

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,349
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD